TY - JOUR
AU - Brøsen, Kim
AB - In 2022, the pandemic continued to loosen its grip on society in most countries, and things have almost returned to normal. Again, we could all travel more and begin to meet with friends and with colleagues at scientific meetings, and this has been a great relief. On a personal note, the Editor‐In‐Chief participated in his first international congress in three years when he went to Athens in June to receive the Lifetime Achievement Award for 2021 of the European Association for Clinical Pharmacology and Therapeutics (EACPT).The Impact Factor of BCPT for 2021 dropped slightly from 4.080 in 2020 to 3.688 in 2021, which was predicted and still is the second highest value ever. We will continue to make every effort to publish high‐quality, peer‐reviewed, citable scientific papers, and hopefully the Impact Factor for the years to come will continue to rise.I, the undersigned Professor Kim Brøsen, University of Southern Denmark, was awarded the BCPT Nordic Prize 2022 in Basic and Clinical Pharmacology and Toxicology.1 Associate Professor Tore B. Stage, University of Southern Denmark, was awarded the BCPT Young Researcher Award 2022 in Basic and Clinical Pharmacology.2 Dr. Stella Karsten from Sweden was awarded the BCPT Young Investigator's Award 2022 
TI - Letter from the editor
JF - Basic and Clinical Pharmacology & Toxicology
DO - 10.1111/bcpt.13819
DA - 2023-01-01
UR - https://www.deepdyve.com/lp/wiley/letter-from-the-editor-YlSTpzD1h5
SP - 3
EP - 4
VL - 132
IS - 1
DP - DeepDyve
ER -